Publication | Closed Access

Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175

Chemoprevention StrategyNovel Cytotoxic RutheniumOncogenic AgentMedicinePharmacologyColorectal CancerCell DeathAnti-cancer AgentOncologyCell BiologyOrganometallic AgentTumor MicroenvironmentCancer ResearchCellular Responses